GGrantIndex
← Leaderboards

Ting C Zhao

Women And Infants Hospital-Rhode Island

$7,339,608
Attributed
$7,339,608
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $839.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,339,608 · 7

By mechanism

R01$6,635,404 · 3
P20$704,204 · 4

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Physiological

Research focus

PhysiologicalCardiacSignal TransductionMyocardialSignal PathwayMyocardial InfarctionInjuryResponseInsightHeartMyocardial IschemiaAnimal ModelGeneticDeacetylationIn VitroHdac4 GeneCardiovascular DiseasesAcetylationNovel Therapeutic InterventionAttenuatedMolecularNovel TherapeuticsBiologicalMediating

Grant awards (23)

A novel protective mechanism in hemorrhagic shock$348,826
R01 · FY2025 · GM · contact PI
A novel protective mechanism in hemorrhagic shock$336,202
R01 · FY2023 · GM · contact PI
A novel protective mechanism in hemorrhagic shock$336,202
R01 · FY2022 · GM · contact PI
A novel protective mechanism in hemorrhagic shock$222,950
R01 · FY2022 · GM · contact PI
A novel protective mechanism in hemorrhagic shock$411,450
R01 · FY2021 · GM · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$409,562
R01 · FY2020 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$243,670
R01 · FY2018 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$192,686
R01 · FY2018 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$425,750
R01 · FY2017 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$425,750
R01 · FY2016 · HL · contact PI
p38 acetylation: Novel signaling mechanisms and myocardial protection$414,086
R01 · FY2016 · HL · contact PI
p38 acetylation: Novel signaling mechanisms and myocardial protection$422,627
R01 · FY2015 · HL · contact PI
p38 acetylation: Novel signaling mechanisms and myocardial protection$400,012
R01 · FY2014 · HL · contact PI
p38 acetylation: Novel signaling mechanisms and myocardial protection$387,739
R01 · FY2013 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$416,962
R01 · FY2012 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$423,169
R01 · FY2011 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$415,430
R01 · FY2010 · HL · contact PI
Histone Deacetylase Inhibition: A Novel Approach to Cardioprotection$402,331
R01 · FY2009 · HL · contact PI
TRANSCRIPTIONAL REGULATION OF THE B1AR BY C-MYC$165,654
P20 · FY2008 · RR · contact PI
TRANSCRIPTIONAL REGULATION OF THE B1AR BY C-MYC$122,777
P20 · FY2007 · RR · contact PI
TRANSCRIPTIONAL REGULATION OF THE B1AR BY C-MYC$129,309
P20 · FY2006 · RR · contact PI
TRANSCRIPTIONAL REGULATION OF THE B1AR BY C-MYC$172,940
P20 · FY2005 · RR
TRANSCRIPTIONAL REGULATION OF THE B1AR BY C-MYC$113,524
P20 · FY2004 · RR